The mandates cover:
1) The acquisition of not more than 1 800 000 series A shares, whereof a maximum of 1 700 000 may be transferred to option holders under the performance-based personnel option plan 2026.
2) The acquisition of not more than 20 000 series A shares, later to be sold on the market in connection with payment to Board members who have opted to receive synthetic shares as part of their remuneration.
3) The sale of not more than 60 000 series A shares to cover costs related to previously issued synthetic shares to Board members.
4) The sale of a maximum 2 600 000 series A shares currently held by the company, for the purpose of covering costs of fulfilling obligations related to the performance-based personnel option plans 2019, 2020, 2021, 2022 and 2023.
Repurchases and sales are subject to market conditions, regulatory restrictions and the capital structure at any given time.
The number of issued shares is presently 1 213 738 703 whereof 823 765 854 series A shares and 389 972 849 series B shares.
For more information please contact:
+46 10 755 0106
ir@epiroc.com
+46 70 347 2455
media@epiroc.com
https://news.cision.com/epiroc/r/epiroc-to-utilize-mandates-to-repurchase-and-sell-shares,c4344490
https://mb.cision.com/Main/16899/4344490/4077781.pdf
(c) 2026 Cision. All rights reserved., source


















